Reference number : GC-2017-Q1-00254, amendment number : , agreement type : G, recipient legal name : Menon, Carlo (Simon Fraser University), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Collaborative Health Research Projects, program name french : Projets de recherche concertée sur la santé, program purpose english : Parkinsons disease is the second most common progressive disorder of the nervous system._x000D_
Parkinsons disease symptoms include slowed movements with impaired posture and_x000D_
balance, freezing of gait (defined as feet glued to the floor) and falls. Every year_x000D_
approximately 5,500 new cases are diagnosed in Canada, costing more than $30 billion_x000D_
annually to the Canadian healthcare system. The traditional dopamine therapy and other_x000D_
alternative technologies (such as enhanced eye glasses or deep brain stimulation) have little_x000D_
to no effect on improving the walking pattern of individuals with Parkinsons disease or are_x000D_
invasive and expensive to administer. Therefore, there is a crucial need for novel_x000D_
technologies to improve gait pattern in individuals with Parkinsons disease. Building on_x000D_
recent technological advancements of the team, an innovative technology is proposed to_x000D_
assist individuals with Parkinsons Disease to restore their ability to walk in environments they_x000D_
find to be challenging, thus improving their independence., program purpose french : Parkinsons disease is the second most common progressive disorder of the nervous system._x000D_
Parkinsons disease symptoms include slowed movements with impaired posture and_x000D_
balance, freezing of gait (defined as feet glued to the floor) and falls. Every year_x000D_
approximately 5,500 new cases are diagnosed in Canada, costing more than $30 billion_x000D_
annually to the Canadian healthcare system. The traditional dopamine therapy and other_x000D_
alternative technologies (such as enhanced eye glasses or deep brain stimulation) have little_x000D_
to no effect on improving the walking pattern of individuals with Parkinsons disease or are_x000D_
invasive and expensive to administer. Therefore, there is a crucial need for novel_x000D_
technologies to improve gait pattern in individuals with Parkinsons disease. Building on_x000D_
recent technological advancements of the team, an innovative technology is proposed to_x000D_
assist individuals with Parkinsons Disease to restore their ability to walk in environments they_x000D_
find to be challenging, thus improving their independence., agreement title english : Restoring normal gait: a disruptive assistive technology, agreement title french : Restoring normal gait: a disruptive assistive technology, agreement number : CHRPJ, agreement value : 251314.0, agreement start date : 2017-04-25, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year. (2017-2018 to 2020-2021), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier. (2017-2018 à 2020-2021), owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada